Current Report Filing (8-k)
16 2월 2023 - 10:31PM
Edgar (US Regulatory)
0000856984
false
0000856984
2023-02-16
2023-02-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (date of earliest event reported): February 16, 2023
QHSLab,
Inc.
(Exact
Name of Registrant as Specified in its Charter)
0-19041
(Commission
File No.)
Nevada |
|
30-1104301 |
(State
of
Incorporation) |
|
(I.R.S.
Employer
Identification
No.) |
|
|
|
901
Northpoint Parkway Suite 302 West Palm Beach
FL
33407 |
|
33407 |
(Address of Principal Executive
Offices) |
|
(ZIP Code) |
Registrant’s
telephone number, including area code: (929) 379-6503
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) |
Securities
registered pursuant to Section 12(g) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.0001
par value |
|
USAQ |
|
N/A |
Item
7.01 Regulation FD Disclosure.
On
February 16, 2023, we, QHSLab, Inc. (the “Company”), issued a press release entitled, QHSLab, Inc. Announces representation
agreement with Healthcare Information Technology Specialists of Florida. The full text of this press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K.
The
information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information
in the Report that is required to be disclosed solely by Regulation FD.
We
do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change
in events, conditions, or circumstances on which any forward-looking statement is based.
By
filing this Current Report on Form 8-K and furnishing the information contained herein, we make no admission as to the materiality of
any information in this report that is required to be disclosed solely by reason of Regulation FD. We use, and will continue to use,
our website (https://usaqcorp.com), press releases, and various social media channels, including our Twitter account (https://twitter.com/qhslapinc),
LinkedIn account (https://www.linkedin.com/company/65407282/admin/), Facebook account (https://www.facebook.com/QHSLabs and
Instagram account (https://www.instagram.com/qhslabs/) as additional means of disclosing public information to investors, the
media and others interested in the Company. It is possible that certain information we post on our website, disseminate in press releases
and on social media could be deemed to be material information, and we encourage investors, the media and others interested in the Company
to review the business and financial information that we post on our website, disseminate in press releases and on the social media channels
identified above, as such information could be deemed to be material information.
Item
9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d)
Exhibits.
The
exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.
SIGNATURES
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Date: February 16, 2023 |
|
|
|
|
QHSLab, Inc. |
|
|
|
|
|
/s/ Troy
Grogan |
|
Name: |
Troy Grogan |
|
Title: |
CEO and Chairman |
|
QHSLab (QB) (USOTC:USAQ)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
QHSLab (QB) (USOTC:USAQ)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
QHSLab Inc (QB) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Qhslab, Inc. News Articles